原发性胆汁性胆管炎合并干燥综合征患者的临床特征
Clinical Characteristics of Patients with Primary Biliary Cholangitis Complicated with Sjogren’s Syndrome
DOI: 10.12677/ACM.2023.132379, PDF,   
作者: 赵晨阳:青岛大学附属医院风湿免疫科,山东 青岛;胡川宁*:青岛大学附属医院护理部,山东 青岛
关键词: 原发性胆汁性胆管炎干燥综合征Primary Biliary Cholangitis Sj?gren’s Syndrome
摘要: 目的:探讨原发性胆汁性胆管炎(PBC)合并干燥综合征(SS)的临床特点。方法:对334例原发性胆汁性胆管炎(PBC)患者进行了筛查,并评估了患者的自身免疫性疾病(AIDs)总体受累程度。然后比较有无SS的PBC病例的实验室和临床结果的差异,讨论了PBC与自身免疫性疾病发病率之间的不同关联。结果:女性PBC患者合并SS的比例高于单纯PBC患者的比例。与单纯PBC患者相比,合并SS的PBC患者的抗Ro-52、抗SSA、抗SSB、抗ds-DNA、ACA、ANuA、AHA抗体阳性率更高(p < 0.05),出现恶心、下肢水肿、脾大、食管胃静脉曲张的可能性更大(p < 0.05)。伴有SS的PBC患者ALT、AST、ALB、ALP、γ-GT、TBIL、DBIL、IBIL、IgG、IgA水平高于单纯PBC患者,而IgM水平低于单纯PBC患者(p < 0.05)。SLE、RA和HT在合并SS的PBC患者中比单纯PBC患者更常见(p < 0.05)。结论:所取得的研究结果表明,合并SS的PBC患者的预后可能优于没有SS的PBC患者,尽管前者更有可能更易合并其他自身免疫性疾病。
Abstract: Objective: To investigate the clinical characteristics of primary biliary cholangitis (PBC) complicated with Sjogren’s syndrome. Methods: In total, 334 Chinese Primary biliary cholangitis (PBC) cases were screened for autoimmune diseases (AIDs), and overall involvement was evaluated. Discrepan-cies in the laboratory and clinical achievements were then compared between PBC cases without and with SS, and the diverse associations between PBC and the incidence of AIDs were then dis-cussed. Result: The proportion of women with PBC and SS was higher than that among PBC patients alone. Relative to PBC cases, PBC cases with SS were also more possible to be positive for anti-Ro-52, anti-SSA, anti-SSB, ACA, anti-dsDNA, ANuA, and AHA antibodies (p < 0.05), and were more possible to undergo nausea, lower limb edema, splenomegaly, and esophagogastric varices (p < 0.05). The levels of ALT, AST, ALB, ALP, γ-GT, TBIL, DBIL, IBIL, IgG, and IgA were greater in PBC cases suffering from SS relative to those in patients with PBC alone, whereas the levels of IgM were lesser in the former patients (p < 0.05). The presentation of SLE, RA, and HT was more common in PBC patients with SS relative to patients with PBC alone (p < 0.05). Conclusion: The achieved findings demon-strate that the prognosis of PBC cases suffering from SS tends to be better than that of PBC patients without SS, although the former patient population is more likely to exhibit other comorbid AIDs.
文章引用:赵晨阳, 胡川宁. 原发性胆汁性胆管炎合并干燥综合征患者的临床特征[J]. 临床医学进展, 2023, 13(2): 2690-2699. https://doi.org/10.12677/ACM.2023.132379

参考文献

[1] Skopouli, F.N. and Moutsopoulos, H.M. (1994) Autoimmune Epithelitis: Sjogren’s Syndrome. Clinical and Experi-mental Rheumatology, 12, S9-S11.
[2] Selmi, C., Bowlus, C.L., Gershwin, M.E., et al. (2011) Primary Biliary Cirrho-sis. The Lancet, 377, 1600-1609. [Google Scholar] [CrossRef
[3] Chalifoux, S.L., Konyn, P.G., Choi, G., et al. (2017) Extra-hepatic Manifestations of Primary Biliary Cholangitis. Gut and Liver, 11, 771-780. [Google Scholar] [CrossRef] [PubMed]
[4] Heathcote, E.J. (2000) Management of Primary Biliary Cirrhosis. The American Association for the Study of Liver Diseases Practice Guidelines. Hepatology, 31, 1005-1013. [Google Scholar] [CrossRef] [PubMed]
[5] (1980) Preliminary Criteria for the Classification of Systemic Sclerosis (Scleroderma). Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis & Rheumatology, 23, 581-590. [Google Scholar] [CrossRef] [PubMed]
[6] Vitali, C., Bombardieri, S., Jonsson, R., et al. (2002) Classification Criteria for Sjogren’s Syndrome: A Revised Version of the European Criteria Proposed by the American-European Consensus Group. Annals of Rheumatic Diseases, 61, 554-558. [Google Scholar] [CrossRef] [PubMed]
[7] Petri, M., Orbai, A.M., Alarcon, G.S., et al. (2012) Derivation and Validation of the Systemic Lupus International Collabo-rating Clinics Classification Criteria for Systemic Lupus Erythematosus. Arthritis & Rheumatology, 64, 2677-2686. [Google Scholar] [CrossRef] [PubMed]
[8] Arnett, F.C., Edworthy, S.M., Bloch, D.A., et al. (1988) The American Rheumatism Association 1987 Revised Criteria for the Classification of Rheumatoid Arthritis. Arthritis & Rheuma-tology, 31, 315-324. [Google Scholar] [CrossRef] [PubMed]
[9] Aletaha, D., Neogi, T., Silman, A.J., et al. (2010) 2010 Rheumatoid Arthritis Classification Criteria: An American College of Rheumatology/European League against Rheumatism Col-laborative Initiative. Arthritis & Rheumatology, 62, 2569-2581. [Google Scholar] [CrossRef] [PubMed]
[10] Bohan, A. and Peter, J.B. (1975) Polymyositis and Dermatomyositis (First of Two Parts). The New England Journal of Medicine, 292, 344-347. [Google Scholar] [CrossRef
[11] Umehara, H., Okazaki, K., Masaki, Y., et al. (2012) Comprehensive Diagnostic Criteria for IgG4-Related Disease (IgG4-RD), 2011. Modern Rheumatology, 22, 21-30. [Google Scholar] [CrossRef] [PubMed]
[12] Li, Y., Nishihara, E., Hirokawa, M., et al. (2010) Distinct Clinical, Serological, and Sonographic Characteristics of Hashimoto’s Thyroiditis Based with and without IgG4-Positive Plasma Cells. The Journal of Clinical Endocrinology & Metabolism, 95, 1309-1317. [Google Scholar] [CrossRef] [PubMed]
[13] Selmi, C., Meroni, P.L. and Gershwin, M.E. (2012) Primary Biliary Cirrhosis and Sjogren’s Syndrome: Autoimmune Epithelitis. Journal of Autoimmunity, 39, 34-42. [Google Scholar] [CrossRef] [PubMed]
[14] Selmi, C. and Gershwin, M.E. (2017) Chronic Autoimmune Ep-ithelitis in Sjogren’s Syndrome and Primary Biliary Cholangitis: A Comprehensive Review. Rheumatology and Ther-apy, 4, 263-279. [Google Scholar] [CrossRef] [PubMed]
[15] Tanaka, A. (2021) Current Understanding of Primary Biliary Cholangitis. Clinical and Molecular Hepatology, 27, 1-21. [Google Scholar] [CrossRef] [PubMed]
[16] Floreani, A., Franceschet, I., Cazzagon, N., et al. (2015) Extrahepat-ic Autoimmune Conditions Associated with Primary Biliary Cirrhosis. Clinical Reviews in Allergy & Immunology, 48, 192-197. [Google Scholar] [CrossRef] [PubMed]
[17] Gershwin, M.E., Selmi C., Worman, H.J., et al. (2005) Risk Factors and Comorbidities in Primary Biliary Cirrhosis: A Controlled Interview-Based Study of 1032 Patients. Hepa-tology, 42, 1194-1202. [Google Scholar] [CrossRef] [PubMed]
[18] Anaya, J.M., Rojas-Villarraga, A., Mantilla, R.D., et al. (2016) Polyautoimmunity in Sjogren Syndrome. Rheumatic Disease Clinics of North America, 42, 457-472. [Google Scholar] [CrossRef] [PubMed]
[19] Mason, D.K., Harden, R.M. and Alexander, W.D. (1967) The Salivary and Thyroid Glands. A Comparative Study in Man. British Dental Journal, 122, 485-489.
[20] Abbas, Z., Asim, M., Saeed, A., et al. (2021) The Spectrum of Autoimmune Liver Disorders, Clinical Presentation, and Autoan-tibodies in Patients from a Tertiary Care Center in Pakistan. Cureus, 13, e19789. [Google Scholar] [CrossRef] [PubMed]
[21] Rain, F., Durieu, I., Mackiewitz, R., et al. (1996) Dermatopolymyositis and Primary Biliary Cirrhosis. A Rare Association. La Presse Médicale, 25, 581-582.
[22] Pamfil, C., Candrea, E., Berki, E., et al. (2015) Primary Biliary Cirrhosis—Autoimmune Hepatitis Overlap Syndrome Associated with Derma-tomyositis, Autoimmune Thyroiditis and Antiphospholipid Syndrome. Journal of Gastrointestinal and Liver Diseases, 24, 101-104. [Google Scholar] [CrossRef] [PubMed]
[23] Tang, N., Jiao, Y., Wang, Y., et al. (2020) Inflam-matory Demyelinating Pseudotumor with Liver Dysfunction: IgG4 Related Disease with Primary Biliary Cholangitis. The American Journal of the Medical Sciences, 360, 410-413. [Google Scholar] [CrossRef] [PubMed]
[24] Smyk, D., Cholongitas, E., Kriese, S., et al. (2011) Primary Biliary Cirrhosis: Family Stories. Autoimmune Diseases, 2011, Article ID: 189585. [Google Scholar] [CrossRef] [PubMed]
[25] Efe, C., Wahlin, S., Ozaslan, E., et al. (2012) Autoimmune Hepati-tis/Primary Biliary Cirrhosis Overlap Syndrome and Associated Extrahepatic Autoimmune Diseases. European Journal of Gastroenterology & Hepatology, 24, 531-534. [Google Scholar] [CrossRef
[26] Podda, M., Selmi, C., Lleo, A., et al. (2013) The Limita-tions and Hidden Gems of the Epidemiology of Primary Biliary Cirrhosis. Journal of Autoimmunity, 46, 81-87. [Google Scholar] [CrossRef] [PubMed]
[27] Wang, L., Gershwin, M.E. and Wang, F.S. (2016) Primary Bili-ary Cholangitis in China. Current Opinion in Gastroenterology, 32, 195-203. [Google Scholar] [CrossRef
[28] Sun, Y., Haapanen, K., Li, B., et al. (2015) Women and Primary Biliary Cirrhosis. Clinical Reviews in Allergy & Immunology, 48, 285-300. [Google Scholar] [CrossRef] [PubMed]
[29] Sun, Y., Zhang, W., Li, B., et al. (2015) The Coexistence of Sjogren’s Syndrome and Primary Biliary Cirrhosis: A Comprehensive Review. Clinical Reviews in Allergy & Immu-nology, 48, 301-315. [Google Scholar] [CrossRef] [PubMed]
[30] Banhuk, F.W., Pahim, B.C., Jorge, A.S., et al. (2018) Relation-ships among Antibodies against Extractable Nuclear Antigens, Antinuclear Antibodies, and Autoimmune Diseases in a Brazilian Public Hospital. Autoimmune Diseases, 2018, Article ID: 9856910. [Google Scholar] [CrossRef] [PubMed]
[31] Lammers, W.J., Hirschfield, G.M., Corpechot, C., et al. (2015) De-velopment and Validation of a Scoring System to Predict Outcomes of Patients with Primary Biliary Cirrhosis Re-ceiving Ursodeoxycholic Acid Therapy. Gastroenterology, 149, 1804-1812e4. [Google Scholar] [CrossRef] [PubMed]
[32] Lindor, K.D., Bowlus, C.L., Boyer, J., et al. (2019) Primary Biliary Cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver Diseases. Hepatolo-gy, 69, 394-419. [Google Scholar] [CrossRef] [PubMed]
[33] Smith, A., Baumgartner, K. and Bositis, C. (2019) Cir-rhosis: Diagnosis and Management. American Family Physician, 100, 759-770.
[34] Prince, M.I., Chetwynd, A., Craig, W.L., et al. (2004) Asymptomatic Primary Biliary Cirrhosis: Clinical Features, Prognosis, and Symptom Pro-gression in a Large Population Based Cohort. Gut, 53, 865-870. [Google Scholar] [CrossRef] [PubMed]
[35] Tsianos, E.V., Hoofnagle, J.H., Fox, P.C., et al. (1990) Sjogren’s Syndrome in Patients with Primary Biliary Cirrhosis. Hepatology, 11, 730-734. [Google Scholar] [CrossRef] [PubMed]
[36] Uddenfeldt, P., Danielsson, A., Forssell, A., et al. (1991) Features of Sjogren’s Syndrome in Patients with Primary Biliary Cirrhosis. Journal of Internal Medicine, 230, 443-448. [Google Scholar] [CrossRef] [PubMed]
[37] Rigamonti, C., Shand, L., Feudjo, M., et al. (2006) Clinical Features and Prognosis of Primary Biliary Cirrhosis Associated with Systemic Sclerosis. Gut, 55, 388-394. [Google Scholar] [CrossRef] [PubMed]
[38] Zhang, L.N., Shi, T.Y., Shi, X.H., et al. (2013) Early Biochemical Response to Ursodeoxycholic Acid and Long-Term Prognosis of Primary Biliary Cirrhosis: Results of a 14-Year Co-hort Study. Hepatology, 58, 264-272. [Google Scholar] [CrossRef] [PubMed]
[39] Varin, M.M., Le Pottier, L., Youinou, P., et al. (2010) B-Cell Tolerance Breakdown in Sjogren’s Syndrome: Focus on BAFF. Autoimmunity Reviews, 9, 604-608. [Google Scholar] [CrossRef] [PubMed]
[40] Gan, Y., Zhao, X., He, J., et al. (2017) Increased Interleu-kin-17F Is Associated with Elevated Autoantibody Levels and More Clinically Relevant than Interleukin-17A in Pri-mary Sjogren’s Syndrome. Journal of Immunology Research, 2017, Article ID: 4768408. [Google Scholar] [CrossRef] [PubMed]
[41] Li, Y., Wang, W., Tang, L., et al. (2015) Chemokine (C-X-C Motif) Ligand 13 Promotes Intrahepatic Chemokine (C-X-C Motif) Receptor 5+ Lymphocyte Homing and Aberrant B-Cell Immune Responses in Primary Biliary Cirrhosis. Hepatology, 61, 1998-2007. [Google Scholar] [CrossRef] [PubMed]
[42] Chung, B.K., Guevel, B.T., Reynolds, G.M., et al. (2017) Phenotyping and Auto-Antibody Production by Liver-Infiltrating B Cells in Primary Sclerosing Cholangitis and Primary Biliary Cholangitis. Journal of Autoimmunity, 77, 45-54. [Google Scholar] [CrossRef] [PubMed]
[43] Chen, W.Q., Dai, X.N., Yu, Y., et al. (2020) Analysis of Clinical Features and Prognosis in Patients with Primary Sjogren’s Syndrome and Autoimmune Liver Disease. Journal of Pe-king University. Health Sciences, 52, 886-891.